Effectiveness of Point of Care Complete Blood Cell Count Analyzer in Reducing Time to Results

Laboratory Problem Clinical Trial

Official title:

Effectiveness of Point of Care Complete Blood Cell Count Analyzer in Reducing Time to Results

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT04769336
• Other study ID #: 21-009-LFH
• Status: Not yet recruiting
• Start date: April 1, 2021
• Est. completion date: March 31, 2022

Study information

• Verified date: February 2021
• Source: Northwestern Medicine
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The current process for getting complete blood cell counts (CBC) results in the operating room during surgery relies on sending blood samples from the operating room to the hospital's central lab. This workflow is complex and often results in handing off the blood sample to 4 or more different staff members before arriving in the lab for analysis. This often causes delayed CBC results, which may lead to inappropriate or delayed clinical decision making. By providing prompt access to CBC results with the use of a point of care CBC analyzer, the clinical workflow efficiency can be significantly improved. This should resulting in better clinical decision making, reductions in costs, increase in patient satisfaction and facilitation of hospital processes.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 100
• Est. completion date: March 31, 2022
• Est. primary completion date: March 31, 2022
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 10 Years to 85 Years

Eligibility

Inclusion Criteria:

• All English speaking patients, 18 years or older, having surgery in the Lake Forest Hospital operating rooms, with a pre-existing indication for CBC analysis.

Exclusion Criteria:

• All patients not meeting inclusion criteria or protected patient populations, specifically, pregnant women, prisoners, cognitively impaired patients, patients unable to consent, students, employees, and children)

Related Conditions & MeSH terms

• Laboratory Problem

Intervention

Device:
• Central Lab based CBC
lab samples will be sent to the central lab for CBC analysis
• Point of Care CBC
lab samples will be analyzed at point of care

Locations

Country	Name	City	State
United States	Northwestern Lake Forest Hospital	Lake Forest	Illinois

Sponsors (1)

Lead Sponsor	Collaborator
Northwestern Medicine

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Time to result	Time between blood draw and CBC result displayed in Electronic medical record	Through study completion, an average of 1 year